ArticleJournal of neurosurgery. Case lessons2026
Spinal cord stimulation for idiopathic spinal myoclonus: illustrative case.
Article in Journal of neurosurgery. Case lessons, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSpinal myoclonus is a rare movement disorder characterized by sudden, involuntary jerking movements arising from segmental spinal circuitry. Treatment is primarily directed toward underlying etiologies or symptomatic control with antiepileptic medications, botulinum toxin injections, or intrathecal therapies. Evidence supporting spinal cord stimulation (SCS) remains limited to isolated reports involving secondary etiologies such as cervical myelopathy or complex regional pain syndrome. The role of SCS in idiopathic segmental spinal myoclonus remains poorly defined. OBSERVATIONS: An 83-year-old woman with medically refractory segmental spinal myoclonus involving the right paraspinal musculature, shoulder girdle, and upper back experienced near-complete resolution of symptoms following thoracic SCS after unsuccessful treatment with multiple medications and botulinum toxin injections. Permanent implantation resulted in sustained symptomatic improvement with complete resolution of jerks at the 7-month follow-up. LESSONS: SCS may represent a promising neuromodulatory strategy for patients with idiopathic segmental spinal myoclonus refractory to conventional therapy. This case expands the limited literature supporting the use of SCS in spinal myoclonus and suggests a potential role for dorsal column neuromodulation even in the absence of structural spinal pathology. https://thejns.org/doi/10.3171/CASE26322.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.